Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases

Background: The correlation of S100A8/S100A9 with various inflammatory conditions, including autoimmune diseases have been reported. There is no study investigating the levels of S100A8/S100A9 in autoimmune thyroid diseases (AITD) Aims: We aimed to evaluate the level of serum S100A8/S100A9 in AIT...

Full description

Bibliographic Details
Main Authors: Hakan Korkmaz, Suzan Tabur, Esen Savaş, Mesut Özkaya, Nurten Aksoy, Şefika Nur Aksoy, Ersin Akarsu
Format: Article
Language:English
Published: Galenos Publishing House 2016-10-01
Series:Balkan Medical Journal
Subjects:
Online Access:http://balkanmedicaljournal.org/text.php?lang=en&id=12
_version_ 1797922618404241408
author Hakan Korkmaz
Suzan Tabur
Esen Savaş
Mesut Özkaya
Nurten Aksoy
Şefika Nur Aksoy
Ersin Akarsu
author_facet Hakan Korkmaz
Suzan Tabur
Esen Savaş
Mesut Özkaya
Nurten Aksoy
Şefika Nur Aksoy
Ersin Akarsu
author_sort Hakan Korkmaz
collection DOAJ
description Background: The correlation of S100A8/S100A9 with various inflammatory conditions, including autoimmune diseases have been reported. There is no study investigating the levels of S100A8/S100A9 in autoimmune thyroid diseases (AITD) Aims: We aimed to evaluate the level of serum S100A8/S100A9 in AITD. Study Design: Case control study. Methods: Fifty patients with AITD (25 Hashimoto’s thyroiditis (HT) and 25 Graves’ disease (GD)) were included in the study. Twenty seven healthy subjects participated as a control group. Blood samples were obtained in the 3 months after the initiation of medical treatment. Serum levels of total antioxidant status (TAS), total oxidative status (TOS), total free sulfhydryl (SH), lipid hydroperoxide (LOOH) and S100A8/S100A9 were analyzed. Results: The patients with AITD had significantly higher S100A8/S100A9, OSI, LOOH and TOS levels than the healthy control group. There was no significant difference between GD and HT patients in terms of S100A8/S100A9, TOS and OSI levels. S100A8/S100A9 level was positively correlated with LOOH, TOS and OSI levels but negatively correlated with –SH level in the patients with AITD. Conclusion: Serum S100A8/S100A9 levels were increased in patients with AITD and positively correlated with LOOH, TOS and OSI whereas negatively correlated with SH.
first_indexed 2024-04-10T14:35:18Z
format Article
id doaj.art-b97f8df912ac4ef5a71ab0174df2f8f3
institution Directory Open Access Journal
issn 2146-3123
2146-3131
language English
last_indexed 2024-04-10T14:35:18Z
publishDate 2016-10-01
publisher Galenos Publishing House
record_format Article
series Balkan Medical Journal
spelling doaj.art-b97f8df912ac4ef5a71ab0174df2f8f32023-02-15T16:08:39ZengGalenos Publishing HouseBalkan Medical Journal2146-31232146-31312016-10-0133554755110.5152/balkanmedj.2016.15881Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid DiseasesHakan Korkmaz0Suzan Tabur1Esen Savaş2Mesut Özkaya3Nurten Aksoy4Şefika Nur Aksoy5Ersin Akarsu6Department of Endocrinology and Metabolic Disease, Edirne State Hospital, Edirne, TurkeyDivision of Endocrinology, Department of Internal Medicine, Gaziantep University School of Medicine, Gaziantep, TurkeyDepartment of Internal Medicine, Gaziantep University School of Medicine, Gaziantep, TurkeyDivision of Endocrinology, Department of Internal Medicine, Gaziantep University School of Medicine, Gaziantep, TurkeyDepartment of Clinical Biochemistry, Harran University School of Medicine, Şanlıurfa, TurkeyDepartment of Clinical Biochemistry, Gaziantep University School of Medicine, Gaziantep, TurkeyDivision of Endocrinology, Department of Internal Medicine, Gaziantep University School of Medicine, Gaziantep, TurkeyBackground: The correlation of S100A8/S100A9 with various inflammatory conditions, including autoimmune diseases have been reported. There is no study investigating the levels of S100A8/S100A9 in autoimmune thyroid diseases (AITD) Aims: We aimed to evaluate the level of serum S100A8/S100A9 in AITD. Study Design: Case control study. Methods: Fifty patients with AITD (25 Hashimoto’s thyroiditis (HT) and 25 Graves’ disease (GD)) were included in the study. Twenty seven healthy subjects participated as a control group. Blood samples were obtained in the 3 months after the initiation of medical treatment. Serum levels of total antioxidant status (TAS), total oxidative status (TOS), total free sulfhydryl (SH), lipid hydroperoxide (LOOH) and S100A8/S100A9 were analyzed. Results: The patients with AITD had significantly higher S100A8/S100A9, OSI, LOOH and TOS levels than the healthy control group. There was no significant difference between GD and HT patients in terms of S100A8/S100A9, TOS and OSI levels. S100A8/S100A9 level was positively correlated with LOOH, TOS and OSI levels but negatively correlated with –SH level in the patients with AITD. Conclusion: Serum S100A8/S100A9 levels were increased in patients with AITD and positively correlated with LOOH, TOS and OSI whereas negatively correlated with SH.http://balkanmedicaljournal.org/text.php?lang=en&id=12Autoimmune thyroid diseaseoxidative statusS100A8/S100A9
spellingShingle Hakan Korkmaz
Suzan Tabur
Esen Savaş
Mesut Özkaya
Nurten Aksoy
Şefika Nur Aksoy
Ersin Akarsu
Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
Balkan Medical Journal
Autoimmune thyroid disease
oxidative status
S100A8/S100A9
title Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
title_full Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
title_fullStr Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
title_full_unstemmed Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
title_short Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
title_sort evaluation of serum s100a8 s100a9 levels in patients with autoimmune thyroid diseases
topic Autoimmune thyroid disease
oxidative status
S100A8/S100A9
url http://balkanmedicaljournal.org/text.php?lang=en&id=12
work_keys_str_mv AT hakankorkmaz evaluationofserums100a8s100a9levelsinpatientswithautoimmunethyroiddiseases
AT suzantabur evaluationofserums100a8s100a9levelsinpatientswithautoimmunethyroiddiseases
AT esensavas evaluationofserums100a8s100a9levelsinpatientswithautoimmunethyroiddiseases
AT mesutozkaya evaluationofserums100a8s100a9levelsinpatientswithautoimmunethyroiddiseases
AT nurtenaksoy evaluationofserums100a8s100a9levelsinpatientswithautoimmunethyroiddiseases
AT sefikanuraksoy evaluationofserums100a8s100a9levelsinpatientswithautoimmunethyroiddiseases
AT ersinakarsu evaluationofserums100a8s100a9levelsinpatientswithautoimmunethyroiddiseases